A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF OBINUTUZUMAB IN PATIENTS WITH ISN/RPS 2003 CLASS III OR IV LUPUS NEPHRITIS

Authors
Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2017
This article has no abstract
Epistemonikos ID: af79efa5bb89cbd1a2595549f9ada8e3d5bac4d1
First added on: Apr 16, 2025